department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Plan B One-Step · pharmadog

pharmadog
drugs
Plan B One-Step

drug

patient view →

Postinor

Marketedupdated 2mo ago

by Foundation Consumer Healthcare LLC

Approved

community read0 votes

all catalysts(1)

approval · 1

LEVONORGESTREL — FDA approval

News(0)

no news has mentioned this drug yet

brand

Plan B One-Step

generic

levonorgestrel

indication

Female Contraception

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Feb 7, 2027

215 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (12)

Sep 7, 2040formulationUS 11571328
Mar 22, 2034formulationUS 10028858
Oct 24, 2033method-of-use (U-2348)US 11090186
Oct 6, 2033compositionUS 12004992
Sep 16, 2029method-of-use (U-2948)US 105615243.2y
Sep 16, 2029method-of-use (U-2948)US 105615243.2y
Sep 16, 2029method-of-use (U-2948)US 105615243.2y
Sep 14, 2029formulationUS 118501823.2y
Sep 14, 2029formulationUS 118501823.2y
Sep 14, 2029formulationUS 118501823.2y
Feb 7, 2027formulationUS 11628088215d
Feb 7, 2027formulationUS 11628088215d

FDA exclusivities (1)

Jun 29, 2026I-917Indication (3y)

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

openFDA · ClinicalTrials.gov

last refreshed 2h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Trials studying Postinor

phase1Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)recruitingn=24
phase1A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesityrecruitingn=50
phase1A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participantsrecruitingn=16
phase1A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptivesactive not recruitingn=20
phase1A Study of Elenestinib in Healthy Adult Female Participantscompletedn=20
phase1Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)completedn=24
phase1A Research Study Looking Into the Effect of NNC0519-0130 on Blood Levels of a Birth Control Pill and Emptying of the Stomach in Women After Menopausecompletedn=47
phase1Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepinecompletedn=60

more trials →